Patent · US Active

Kinase inhibitors

US7692005B2 · kind B2 · utility

0Cited by
13References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 12, 2006
Grant dateApr 6, 2010
Priority date
Expiry dateDec 18, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC40B40/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.